Advertisement

Oral Medications For Skin Diseases: 15 Essential Options

Comprehensive guide to oral drugs for treating various skin conditions, including antifungals, immunosuppressants, and retinoids.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Oral medications are essential for managing moderate to severe skin diseases when topical treatments prove inadequate. These drugs target underlying inflammatory, infectious, or hyperproliferative processes in conditions such as psoriasis, eczema, fungal infections, and autoimmune bullous disorders. Selection depends on disease severity, patient factors, and potential side effects.

Immunosuppressants and Anti-inflammatory Agents

Drugs like methotrexate modulate immune responses and reduce inflammation in chronic skin conditions. Methotrexate, a folate antagonist, is widely used for psoriasis and other inflammatory dermatoses.

Methotrexate

Methotrexate treats moderate to severe psoriasis, atopic dermatitis, pityriasis rubra pilaris, pompholyx, chronic actinic dermatitis, cutaneous T-cell lymphoma, pityriasis lichenoides, chronic spontaneous urticaria, immunobullous diseases (e.g., bullous pemphigoid, pemphigus), morphoea, and lupus erythematosus. It is suitable for adults and children over 3 years.

Improvement typically begins within 6-8 weeks, with maximum effects in 5-6 months. In psoriasis, 50-70% of patients achieve a 75% reduction in PASI score.

Mechanisms: Anti-inflammatory via adenosine increase; immune modulation by reducing T-cell homing, neutrophil activity, and cytokines (TNF-α, IL-10, IL-12); antimetabolite action inhibiting DNA synthesis at higher doses.

Dosing: Weekly 2.5-30 mg, commonly 15 mg, adjusted for renal function, age, and weight. Start low (2.5-5 mg) in elderly (>75 years) or low body weight. Take as single dose or split; after meals or bedtime if nauseous. Subcutaneous injections for GI intolerance.

Folic acid supplementation (e.g., 5 mg weekly) mitigates side effects like stomatitis.

Side Effects: Nausea, fatigue, hepatotoxicity (monitor LFTs), bone marrow suppression (CBC monitoring), infections (e.g., shingles), pulmonary fibrosis (rare). Contraindicated in pregnancy, alcoholism, active infection.

Oral Antifungal Medications

Oral antifungals are reserved for extensive, severe, or topical-resistant fungal infections of skin, hair, and nails. Common agents include triazoles (itraconazole, fluconazole, ketoconazole) and allylamines (terbinafine).

Itraconazole (Sporanox™)

Broad-spectrum for dermatophytes, yeasts, and molds. Take after fatty meal with acidic drink. Dosing varies: e.g., 200 mg/day for 7 days for tinea corporis; pulse therapy for onychomycosis (200 mg twice daily for 1 week/month, 2-3 pulses).

Drug interactions: Reduced by CYP3A4 inducers (e.g., rifampicin). Avoid in pregnancy.

Fluconazole (Diflucan™)

Effective for candidiasis and dermatophyte infections (not registered for nails in NZ). Dosing: 50-400 mg weekly for 2-12 months depending on site.

Contraindicated with cisapride; avoid in pregnancy, heart/renal disease. Side effects: nausea, rash, liver enzyme elevation.

Ketoconazole (Nizoral™)

For resistant infections: 200 mg daily after food. Effective against yeasts and dermatophytes.

Terbinafine

Allylamine for dermatophyte infections, especially onychomycosis: 250 mg daily for 6-12 weeks.

Antifungal Resistance: Increasing in azoles and allylamines, especially in immunosuppressed patients or from regions like India. Use culture and MIC testing for resistant cases.

Retinoids

Systemic retinoids like acitretin and alitretinoin treat disorders of keratinization and inflammation.

Acitretin

Used for psoriasis (esp. pustular, erythrodermic), ichthyosis, Darier disease, palmoplantar pustulosis. Dosing: 10-50 mg daily, maintenance 25-30 mg. Teratogenic; avoid pregnancy for 3 years post-treatment.

Side effects: Hyperlipidemia, hepatotoxicity, mucocutaneous dryness. Monitor lipids and LFTs.

Alitretinoin

For severe chronic hand eczema unresponsive to topicals. 30 mg daily for 24 weeks.

Antivirals

Aciclovir

Oral for herpes zoster (shingles), herpes simplex. Dosing: 800 mg 5x/day for 7 days (shingles); 200-400 mg 3-5x/day for 5-10 days (HSV). Reduces duration and severity.

Antimalarials

Hydroxychloroquine, chloroquine for lupus erythematosus, lichen planopilaris, sarcoidosis. Dosing: Hydroxychloroquine 200-400 mg daily. Retinopathy risk requires baseline and periodic eye exams.

Antiandrogens

Spironolactone, cyproterone acetate for acne, hirsutism in women. Spironolactone 50-200 mg daily; monitor potassium.

Other Agents

  • Abrocitinib: JAK inhibitor for atopic dermatitis.
  • Amitriptyline: For neuropathic itch/pruritus.
  • Acne treatments: Isotretinoin for severe nodulocystic acne (0.5-1 mg/kg/day, 4-6 months).

Monitoring Immune-Modulating Drugs

Essential for long-term use (e.g., methotrexate, azathioprine, ciclosporin). Monitor for hepatotoxicity, myelosuppression, infections, skin cancer.

DrugBaseline TestsOngoing Monitoring
MethotrexateCBC, LFTs, renal, hepatitis serologyMonthly CBC/LFTs x3, then 2-3 monthly
CiclosporinBP, renal, lipids, LFTsWeekly BP/renal first month, then monthly
AzathioprineTPMT, CBC, LFTsMonthly CBC/LFTs

Full body skin exams for skin cancer risk on long-term therapy.

Frequently Asked Questions (FAQs)

Q: When are oral antifungals indicated?

A: For extensive/severe fungal infections resistant to topicals, such as widespread tinea or onychomycosis.

Q: How soon does methotrexate work for psoriasis?

A: Benefits in 6-8 weeks; peak effect 5-6 months.

Q: What are common methotrexate side effects?

A: Nausea, liver issues, infections; mitigated by folic acid and monitoring.

Q: Is monitoring required for retinoids?

A: Yes, lipids, LFTs for acitretin; pregnancy tests for females.

Q: Can oral meds cure skin diseases?

A: Many control symptoms; e.g., antifungals cure infections, but psoriasis often requires maintenance.

Safety Considerations

Pregnancy contraindications common (methotrexate, retinoids, antifungals). Drug interactions abound (e.g., itraconazole with statins). Always consult datasheets and national formularies like NZF, BNF.

References

  1. Methotrexate – DermNet New Zealand — Dr Amanda Oakley et al., DermNet NZ. 2015-12. https://sussexcds.co.uk/wp-content/uploads/2019/10/Methotrexate_NZDermNet.pdf
  2. Oral Antifungal Drugs – DermNet — DermNet NZ. 2024. https://dermnetnz.org/cme/fungal-infections/oral-antifungal-drugs
  3. Oral Antifungal Medication – DermNet — DermNet NZ. 2024. https://dermnetnz.org/topics/oral-antifungal-medication
  4. Oral Medications for Skin Diseases – DermNet — DermNet NZ. 2024-07. https://dermnetnz.org/topics/oral-medications-for-skin-diseases
  5. Monitoring Immune-Modulating Drugs – DermNet — DermNet NZ. 2024. https://dermnetnz.org/topics/monitoring-immune-modulating-drugs-used-in-dermatology
  6. Dermatological Guide for Primary Care Physicians — PMC/NCBI. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11188824/
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete